These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11361870

  • 1. Viramune triple combo reduces viral load below limit of detection.
    AIDS Patient Care STDS; 1997 Dec; 11(6):456. PubMed ID: 11361870
    [No Abstract] [Full Text] [Related]

  • 2. Triple therapy in previously untreated patients reduces viral load below limit of detection.
    AIDS Patient Care STDS; 1996 Oct; 10(5):308-9. PubMed ID: 11361526
    [No Abstract] [Full Text] [Related]

  • 3. Viramune triple therapy shows suppression of HIV after 1 year, 7 months.
    AIDS Patient Care STDS; 1997 Dec; 11(6):456-7. PubMed ID: 11361871
    [No Abstract] [Full Text] [Related]

  • 4. Viral load--how low is best?
    TreatmentUpdate; 1998 Dec; 10(10):2-3. PubMed ID: 11366016
    [Abstract] [Full Text] [Related]

  • 5. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    Haubrich R, Richman D.
    JAMA; 1999 Jan 13; 281(2):130-1. PubMed ID: 9917108
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
    Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, Wainberg MA, Smith D, Robinson P, Hall D, Myers M, Lange JM.
    JAMA; 1998 Mar 25; 279(12):930-7. PubMed ID: 9544767
    [Abstract] [Full Text] [Related]

  • 7. Maintaining a low viral load with Nevirapine?
    TreatmentUpdate; 1998 Dec 25; 10(10):3-4. PubMed ID: 11366017
    [Abstract] [Full Text] [Related]

  • 8. Nevirapine triple combo results released.
    Common Factor; 1995 Apr 25; (no 10):21. PubMed ID: 11362346
    [Abstract] [Full Text] [Related]

  • 9. Nevirapine, didanosine, and zidovudine for patients with HIV: the INCAS trial. Italy, Netherlands, Canada, and Australia.
    Clay PG, Rathbun RC, Slater LN.
    JAMA; 1999 Jan 13; 281(2):130; author reply 131. PubMed ID: 9917107
    [No Abstract] [Full Text] [Related]

  • 10. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y, Yasuoka A, Yasuoka C, Genka I, Teruya K, Kikuchi Y, Tachikawa N, Oka S.
    Jpn J Infect Dis; 2000 Dec 13; 53(6):244-5. PubMed ID: 11227023
    [No Abstract] [Full Text] [Related]

  • 11. Update on nevirapine: quest for a niche.
    MacDougall DS.
    J Int Assoc Physicians AIDS Care; 1997 Sep 13; 3(9):37-43. PubMed ID: 11364713
    [Abstract] [Full Text] [Related]

  • 12. Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine.
    Biddle AK, Simpson KN.
    Value Health; 2000 Sep 13; 3(3):186-201. PubMed ID: 16464183
    [Abstract] [Full Text] [Related]

  • 13. Nucleoside combinations for antiretroviral therapy: efficacy of stavudine in combination with either didanosine or lamivudine.
    Fisher M.
    AIDS; 1998 Sep 13; 12 Suppl 3():S9-16. PubMed ID: 15168718
    [Abstract] [Full Text] [Related]

  • 14. Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next?
    Cotton MF, Rabie H, van Zyl GU.
    Clin Infect Dis; 2010 Mar 15; 50(6):909-11. PubMed ID: 20158399
    [No Abstract] [Full Text] [Related]

  • 15. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR, Feigley CE, Lee E, Gu J.
    AIDS; 1998 Jan 22; 12(2):222-4. PubMed ID: 9468376
    [No Abstract] [Full Text] [Related]

  • 16. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM, Chêuc G, Ferchal F, Journot V, Pellegrin I, Sombardier MN, Rancinan C, Cotte L, Madelaine I, Debord T, Decazes JM, ALBI (ANRS 070) Study Group.
    Antivir Ther; 1999 Jan 22; 4 Suppl 3():71-4. PubMed ID: 16021874
    [Abstract] [Full Text] [Related]

  • 17. Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
    Am J Health Syst Pharm; 1998 Jun 01; 55(11):1106, 1108. PubMed ID: 9626369
    [No Abstract] [Full Text] [Related]

  • 18. [Reliability: nevirapine. Highly effective + favorable influence on lipid profile].
    MMW Fortschr Med; 2005 Apr 25; 147 Spec No 1():42-3. PubMed ID: 16385872
    [No Abstract] [Full Text] [Related]

  • 19. [A short-term trial of Didanosine, stavudine, and nevirapine combination therapy for human immunodeficiency virus infection].
    Zheng YH, Yang X, Chang WH.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug 25; 28(4):390. PubMed ID: 14653126
    [No Abstract] [Full Text] [Related]

  • 20. A mixed model for repeated dilution assays.
    Bloch J, Chavance M.
    Biometrics; 1998 Jun 25; 54(2):482-92. PubMed ID: 9629640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.